HCRT and lip and oral cavity carcinoma: Moreover, to our knowledge, our study is the first to suggest that TAC1, HCRT, and GAL methylation is associated with worse DFS and that this may be a critical event in oral cancers, laryngeal cancers, and oropharyngeal cancers, respectively.